BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35995274)

  • 1. Predictive markers in chronic kidney disease.
    Priyadarshini G; Rajappa M
    Clin Chim Acta; 2022 Oct; 535():180-186. PubMed ID: 35995274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
    Alderson HV; Ritchie JP; Pagano S; Middleton RJ; Pruijm M; Vuilleumier N; Kalra PA
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2141-2149. PubMed ID: 27852662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of BTP, NGAL, KIM-1, & ADMA biomarkers in CKD and non-CKD subjects.
    Bansal A; Nigoskar S; Thalquotra M
    Int J Biochem Mol Biol; 2023; 14(3):32-39. PubMed ID: 37456909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
    Lobato GR; Lobato MR; Thomé FS; Veronese FV
    Braz J Med Biol Res; 2017 Mar; 50(5):e6106. PubMed ID: 28380198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome.
    Rysz J; Gluba-Brzózka A; Franczyk B; Jabłonowski Z; Ciałkowska-Rysz A
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28777303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhavsar NA; Köttgen A; Coresh J; Astor BC
    Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG
    Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.
    Foster MC; Coresh J; Bonventre JV; Sabbisetti VS; Waikar SS; Mifflin TE; Nelson RG; Grams M; Feldman HI; Vasan RS; Kimmel PL; Hsu CY; Liu KD;
    Clin J Am Soc Nephrol; 2015 Nov; 10(11):1956-63. PubMed ID: 26350438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-type fatty acid-binding protein and neutrophil gelatinase-associated lipocalin in cats with chronic kidney disease and hyperthyroidism.
    Kongtasai T; Meyer E; Paepe D; Marynissen S; Smets P; Mortier F; Demeyere K; Vandermeulen E; Stock E; Buresova E; Defauw P; Duchateau L; Daminet S
    J Vet Intern Med; 2021 May; 35(3):1376-1388. PubMed ID: 33723886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
    Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
    Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD.
    Matsui K; Kamijo-Ikemori A; Imai N; Sugaya T; Yasuda T; Tatsunami S; Toyama T; Shimizu M; Furuichi K; Wada T; Shibagaki Y; Kimura K
    Clin Exp Nephrol; 2016 Apr; 20(2):195-203. PubMed ID: 26189083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of high salt intake.
    Hosohata K
    Adv Clin Chem; 2021; 104():71-106. PubMed ID: 34462058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum neutrophil gelatinase-associated lipocalin (NGAL), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) levels, and their relations with disease type and activity in inflammatory bowel diseases.
    Korkmaz H; Asıl M; Temel T; Öztürk B; Kebapçılar L
    Turk J Med Sci; 2021 Oct; 51(5):2403-2412. PubMed ID: 33984894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of kidney function in the elderly in relation to the new CKD-EPI formula for estimation of glomerular filtration rate.
    Malyszko J; Bachorzewska-Gajewska H; Malyszko J; Iaina-Levin N; Kobus G; Dobrzycki S
    Arch Med Sci; 2011 Aug; 7(4):658-64. PubMed ID: 22291802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Neutrophil Gelatinase-Associated Lipocalin Associates with New-Onset Chronic Kidney Disease in the General Population.
    Bourgonje AR; Abdulle AE; Bourgonje MF; Kieneker LM; la Bastide-van Gemert S; Gordijn SJ; Hidden C; Nilsen T; Gansevoort RT; Mulder DJ; Dullaart RPF; de Borst MH; Bakker SJL; van Goor H
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).
    Peralta C; Scherzer R; Grunfeld C; Abraham A; Tien P; Devarajan P; Bennett M; Butch A; Anastos K; Cohen M; Nowicki M; Sharma A; Young M; Sarnak M; Parikh C; Shlipak M
    HIV Med; 2014 May; 15(5):291-300. PubMed ID: 24313986
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.